Evidence map›Paper›PMID 27476655›Full record

ArticleAmerican journal of human genetics2016

ARCN1 Mutations Cause a Recognizable Craniofacial Syndrome Due to COPI-Mediated Transport Defects.

Kosuke Izumi, Maggie Brett, Eriko Nishi, Séverine Drunat, Ee-Shien Tan, Katsunori Fujiki, Sophie Lebon, Breana Cham, Koji Masuda, Michiko Arakawa and 14 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. COPI Coatomer Regulates Several Steps of HDL Metabolism.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Identification of a Fetal De Novo Splice Variant inMaternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 6 countries.

Kosuke IzumiResearch Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan; Division of Medical Genetics, Nagano Children's Hospital, Azumino 399-8205, Japan; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Electronic address: izumik1@email.chop.edu.
Maggie BrettKK Research Centre, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Eriko NishiDivision of Medical Genetics, Nagano Children's Hospital, Azumino 399-8205, Japan; Department of Medical Genetics, Shinshu University Graduate School of Medicine, Matsumoto 390-0802, Japan; Life Science Research Center, Nagano Children's Hospital, Azumino 399-8205, Japan.
Séverine DrunatINSERM UMR1141, Hôpital Robert Debré, Paris 75019, France; Département de Génétique, Hôpital Robert Debré, Paris 75019, France.
Ee-Shien TanGenetics Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Katsunori FujikiResearch Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan.
Sophie LebonINSERM UMR1141, Hôpital Robert Debré, Paris 75019, France.
Breana ChamGenetics Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Koji MasudaResearch Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan.
Michiko ArakawaDivision of Medical Genetics, Nagano Children's Hospital, Azumino 399-8205, Japan.
Adeline JacquinetDépartement de Génétique, Centre Hospitalier Universitaire et Université de Liège, Liège 4000, Belgium.
Yusuke YamazumiLaboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032, Japan.
Shu-Ting ChenResearch Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan.
Alain VerloesINSERM UMR1141, Hôpital Robert Debré, Paris 75019, France; Département de Génétique, Hôpital Robert Debré, Paris 75019, France; Université Paris Diderot (Paris 7), Hôpital Robert Debré, Paris 75019, France.
Yuki OkadaLaboratory of Pathology and Development, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan.
Yuki KatouResearch Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan.
Tomohiko NakamuraLife Science Research Center, Nagano Children's Hospital, Azumino 399-8205, Japan.
Tetsu AkiyamaLaboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, University of Tokyo, Tokyo 113-0032, Japan.
Pierre GressensINSERM UMR1141, Hôpital Robert Debré, Paris 75019, France; Université Paris Diderot (Paris 7), Hôpital Robert Debré, Paris 75019, France; The Centre for the Developing Brain, King's College London, St. Thomas' Hospital, London SE1-7EH, UK.
Roger FooGenetics Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore 229899, Singapore; Genome Institute of Singapore, Singapore 138672, Singapore.
Sandrine PassemardINSERM UMR1141, Hôpital Robert Debré, Paris 75019, France; Département de Génétique, Hôpital Robert Debré, Paris 75019, France; Université Paris Diderot (Paris 7), Hôpital Robert Debré, Paris 75019, France.
Ene-Choo TanKK Research Centre, KK Women's and Children's Hospital, Singapore 229899, Singapore; Paediatrics ACP, SingHealth Duke-NUS Medical School, Singapore 169857, Singapore.
Vincent El GhouzziINSERM UMR1141, Hôpital Robert Debré, Paris 75019, France; Université Paris Diderot (Paris 7), Hôpital Robert Debré, Paris 75019, France.
Katsuhiko ShirahigeResearch Center for Epigenetic Disease, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan; CREST, Japan Science and Technology Agency, Kawaguchi, 332-0012, Japan.
The University of Tokyo · JPInserm · FRKK Women's and Children's Hospital · SGNagano Children's Hospital · JPChildren's Hospital of Philadelphia · USJapan Science and Technology Agency · JPShinshu University · JPSingHealth Duke-NUS Academic Medical Centre · SGSt Thomas' Hospital · GBUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular homeostasis is maintained by the highly organized cooperation of intracellular trafficking systems, including COPI, COPII, and clathrin complexes. COPI is a coatomer protein complex responsible for intracellular protein transport between the endoplasmic reticulum and the Golgi apparatus. The importance of such intracellular transport mechanisms is underscored by the various disorders, including skeletal disorders such as cranio-lenticulo-sutural dysplasia and osteogenesis imperfect, caused by mutations in the COPII coatomer complex. In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI. ARCN1 mutant cell lines were revealed to have endoplasmic reticulum stress, suggesting the involvement of ER stress response in the pathogenesis of this disorder. Given that ARCN1 deficiency causes defective type I collagen transport, reduction of collagen secretion represents the likely mechanism underlying the skeletal phenotype that characterizes this condition. Our findings demonstrate the importance of COPI-mediated transport in human development, including skeletogenesis and brain growth.

Indexed as

MutationAdultCoatomer ProteinCoat Protein Complex ICollagenCraniofacial AbnormalitiesEndoplasmic Reticulum StressHeterozygoteHumansInfantInfant, NewbornMaleSyndromeCoatomer ProteinCoat Protein Complex ICollagenARCN1-related syndromeER stressexome sequencingintracellular traffickingmicrocephalic dwarfismmicrognathiashort stature

Identifiers

PMID27476655
PMCPMC4974084
OpenAlexW2492345185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.